Cycloferon tab. p / o c / w sol. 150mg # 50

Dosage form

tablets are biconvex yellow, enteric coated.

Structure

one tablet contains:

active ingredient - meglumine acridone acetate in terms of acridoneacetic acid - 150.00 mg

excipients: povidone - 7.93 mg, calcium stearate - 3.07 mg, hypromellose - 2.73 mg, polysorbate 80 - 0.27 mg, methacrylic acid and ethyl acrylate copolymer - 23.21 mg, propylene glycol - 1.79 mg ...

pharmachologic effect

Cycloferon is a low molecular weight inducer of interferon, which determines a wide range of its biological activity (antiviral, immunomodulatory, anti-inflammatory, etc.).

Cycloferon is effective against herpes viruses, influenza and other pathogens of acute respiratory diseases.

Has a direct antiviral effect, suppressing the reproduction of the virus in the early stages (1–5 days) of the infectious process, reducing the infectivity of viral progeny, leading to the formation of defective viral particles.

Increases the body's nonspecific resistance against viral and bacterial infections.

Pharmacokinetics

When taking a daily dose, the maximum concentration in the blood plasma is achieved after 2-3 hours, gradually decreases by the 8th hour, and after 24 hours Cycloferon is found in trace amounts.

The half-life of the drug is 4–5 hours, so its use in recommended doses does not create conditions for accumulation in the body.

Side effects

Allergic reactions

Selling features

Available without a prescription

Special conditions

Cycloferon does not affect the ability to drive vehicles.

For diseases of the thyroid gland, it is necessary to consult an endocrinologist.

If the next dose of the drug is missed, then as soon as possible, without taking into account the time interval and doubling the dosage, continue the course according to the begun scheme.

In the absence of a therapeutic effect, you must consult a doctor.

There is no information on drug overdose.

Indications

In adults in complex therapy:

flu and acute respiratory diseases

herpes infection

In children from the age of four in complex therapy:

flu and acute respiratory diseases

herpes infection.

In children from the age of four for the prevention of influenza and acute respiratory diseases.

Contraindications

Pregnancy, breastfeeding period, children under 4 years of age (due to imperfect swallowing), individual intolerance to the drug components, decompensated liver cirrhosis.

CAREFULLY

In case of diseases of the digestive system in the stage of exacerbation (erosion, stomach and / or duodenal ulcers, gastritis and duodenitis) and allergic reactions in history, be sure to consult your doctor before taking the drug.

APPLICATION DURING PREGNANCY AND DURING BREASTFEEDING

The use of the drug during pregnancy and during breastfeeding is contraindicated.

Drug interactions

Cycloferon is compatible with all drugs used in the treatment of these diseases (interferons, chemotherapeutic, symptomatic drugs, etc.).

Enhances the action of interferons and nucleoside analogues.

Reduces the side effects of chemotherapy, interferon therapy.

Dosage

Inside, once a day, 30 minutes before meals, without chewing, squeezing 0.5 glasses of water, in age dosages:

children 4–6 years old: 150 mg (1 tablet) per dose

children 7-11 years old: 300-450 mg (2-3 tablets) per appointment

adults and children over 12 years old: 450-600 mg (3-4 tablets) per dose.

It is advisable to repeat the course 2-3 weeks after the end of the first course.

In adults:

1. When treating influenza and acute respiratory diseases, the drug is taken on the 1st, 2nd, 4th, 6th, 8th day (course l

Name ENG

CYCLOFERON

Clinical and pharmacological group

Antiviral and immunomodulatory drug.

Interferon synthesis inductor

ATX code

Other immunostimulants

Dosage

150mg

Structure

1 tablet contains:

active substance: meglumine acridone acetate in terms of acridoneacetic acid - 150 mg

excipients: povidone - 7.93 mg, calcium stearate - 3.07 mg, hypromellose - 2.73 mg, polysorbate 80 - 0.27 mg, methacrylic acid and ethyl acrylate copolymer - 23.21 mg, propylene glycol - 1.79 mg ...

Indications

In adults in complex therapy: influenza and acute respiratory diseases

herpes infection In children from the age of four in complex therapy: influenza and acute respiratory diseases

herpes infection.

In children from the age of four for the prevention of influenza and acute respiratory diseases.

INN / Active ingredient

acridoneacetic acid

Contraindications

Pregnancy, breastfeeding period, children under 4 years of age (due to imperfect swallowing), individual intolerance to the drug components, decompensated liver cirrhosis.

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 2 years

Specifications

Category

Antiviral

,

Antimicrobial agents

Scope of the drug

General

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

fifty

Minimum age from

4 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Polisan

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Immunostimulating agent

Anatomical and therapeutic characteristics

L03AX Other immunostimulants

Dosage form

Enteric-coated tablets

Expiration date in days

730

Package weight, g

thirty

Mode of application

:

Dosage (volume) of the substance in the preparation

:

Meglumine acridone acetate in terms of acridoneacetic acid - 150 mg

Information on technical characteristics, delivery set, country of manufacture